HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 179 filers reported holding HAEMONETICS CORP in Q2 2015. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $11,220,000 | +32.1% | 279,106 | +19.0% | 0.01% | +30.0% |
| Q3 2016 | $8,493,000 | +26.1% | 234,562 | +1.0% | 0.01% | +11.1% |
| Q2 2016 | $6,733,000 | -8.6% | 232,269 | +10.3% | 0.01% | -10.0% |
| Q1 2016 | $7,366,000 | +10.9% | 210,590 | +2.2% | 0.01% | +11.1% |
| Q4 2015 | $6,644,000 | -0.0% | 206,087 | +0.2% | 0.01% | 0.0% |
| Q3 2015 | $6,647,000 | -22.5% | 205,668 | -0.8% | 0.01% | -18.2% |
| Q2 2015 | $8,575,000 | -0.3% | 207,331 | +8.2% | 0.01% | 0.0% |
| Q1 2015 | $8,604,000 | +21.6% | 191,531 | +1.3% | 0.01% | +22.2% |
| Q4 2014 | $7,075,000 | +6.1% | 189,073 | -1.0% | 0.01% | 0.0% |
| Q3 2014 | $6,666,000 | -0.5% | 190,888 | +0.6% | 0.01% | 0.0% |
| Q2 2014 | $6,697,000 | +21.0% | 189,820 | +11.8% | 0.01% | +12.5% |
| Q1 2014 | $5,536,000 | -22.0% | 169,855 | +0.9% | 0.01% | -27.3% |
| Q4 2013 | $7,095,000 | +4.2% | 168,403 | -1.4% | 0.01% | 0.0% |
| Q3 2013 | $6,809,000 | +1.7% | 170,740 | +5.4% | 0.01% | -8.3% |
| Q2 2013 | $6,698,000 | – | 161,983 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BEACONLIGHT CAPITAL, LLC | 95,033 | $8,511,000 | 2.84% |
| Advantage Alpha Capital Partners LP | 100,170 | $8,971,000 | 2.10% |
| Nitorum Capital, L.P. | 395,635 | $35,433,000 | 1.82% |
| Summit Creek Advisors LLC | 127,600 | $11,428,000 | 1.68% |
| Bridge City Capital, LLC | 40,559 | $3,632,000 | 1.67% |
| AEGON ASSET MANAGEMENT UK PLC | 520,408 | $46,603,000 | 1.05% |
| Jackson Square Partners, LLC | 2,298,190 | $205,825,000 | 1.03% |
| Parkman Healthcare Partners LLC | 30,147 | $2,700,000 | 0.76% |
| TEALWOOD ASSET MANAGEMENT INC | 9,154 | $820,000 | 0.54% |
| AMERICAN CAPITAL MANAGEMENT INC | 159,145 | $14,253,000 | 0.52% |